| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |